Preventing Post Phacoemulsification Infection With Intracameral Levofloxacin Administrative
Abstract
Aim: To determine the efficacy of intracameral levofoxacin to prevent post phacoemulsification (phaco) infection.
Material and methods: 2864 eyes of 2032 patients underwent phacoemulsification. Levofloxacin 0.5% given at the end step of surgery intracamerally. Eye conditions, uncorrected visual acuity (UCVA), best corrected visual acuity (BCVA), and intraocular pressure (IOP) were observed and recorded.
Results: There is no observed infection event from day one until one month after surgery. UCVA and BCVA were improved (P<0.001) respectively, and IOP was reduced (P<0.001) on one month after surgery.
Conclusion: Intracameral levofloxacin may be effective to prevent post phaco infection. UCVA, BCVA, and IOP were improved following the absence of infection events.
Read the paper
Related studies
- Ferulic acid regulates the AKT/GSK-3β/CRMP-2 signaling pathway in a middle cerebral artery occlusion animal model
- Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure–Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant Escherichia coli
- Photochemical behavior of levofloxacin
- Correlation Between Dissolution Profiles of Salt-Form Drugs in Biorelevant Bicarbonate Buffer and Oral Drug Absorption: Importance of Dose/ Fluid Volume Ratio
- Evaluation of the synergistic potential and mechanisms of action for de novo designed cationic antimicrobial peptides
- Synthesis of [11C]levofloxacin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.